JFL Life Sciences (NSE:JFLLIFE) EPS (Basic): ₹1.20 (TTM As of Mar. 2025)


NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
66 GF Score
Price ₹9.05
GF Value ₹35.51
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is JFL Life Sciences EPS (Basic)?

JFL Life Sciences NSE:JFLLIFE 66 EPS (Basic) is ₹1.20 as of Mar. 2025. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 66/100 and a GF Value™ of ₹35.51 (Significantly Undervalued). The stock has 2 warning signs investors should review.

JFL Life Sciences's basic earnings per share (Basic EPS) for the six months ended in Mar. 2025 was ₹1.20. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹1.20.

JFL Life Sciences's EPS (Diluted) for the six months ended in Mar. 2025 was ₹1.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹1.20.

JFL Life Sciences's EPS without NRI for the six months ended in Mar. 2025 was ₹1.20. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 1.20.

During the past 12 months, JFL Life Sciences's average EPS without NRIGrowth Rate was 26.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 14.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 66.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, JFL Life Sciences's highest 3-Year average EPS without NRI Growth Rate was 109.80% per year. The lowest was 14.00% per year. And the median was 94.75% per year.

JFL Life Sciences  (NSE:JFLLIFE) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

JFL Life Sciences EPS (Basic) Related Terms

JFL Life Sciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for JFL Life Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences EPS (Basic) Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
Get a 7-Day Free Trial 0.16 0.81 0.92 0.96 1.20

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic) Get a 7-Day Free Trial 0.16 0.81 0.92 0.96 1.20
NSE:JFLLIFE
66GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JFL Life Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

JFL Life Sciences's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(41.586-0)/34.566
=1.20

JFL Life Sciences's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(41.586-0)/34.566
=1.20

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹1.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹1.20 mean?
JFL Life Sciences (NSE:JFLLIFE) has a EPS (Basic) of ₹1.20 as of Mar. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on JFL Life Sciences and its competitors.
Is JFL Life Sciences' EPS (Basic) too high?
JFL Life Sciences' current EPS (Basic) is ₹1.20. Overall, JFL Life Sciences has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' EPS (Basic) compare to ZTS?
JFL Life Sciences' EPS (Basic) of ₹1.20 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on JFL Life Sciences and its competitors. JFL Life Sciences's current EPS (Basic) is ₹1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.51, compared to a current price of ₹9.05 — trading 74.5% below its estimated fair value. The current EPS (Basic) is ₹1.20. JFL Life Sciences' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current EPS (Basic) is ₹1.20 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹9.05 is trading 74.5% below its estimated GF Value™ of ₹35.51. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • EPS (Basic): ₹1.20
  • GF Value™: ₹35.51 vs. price of ₹9.05 (74.5% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
66GF Score

Get the complete analysis for NSE:JFLLIFE

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.05
Price
₹35.51
GF Value